semaglutide california ban update Pharmacy board suspends another Ohio weight loss clinic's license • Ohio Capital Journal The popularity of GLP-1 drugs

The original Sikiric 1999 study likewise reported "evident angiogenic property" and stimulation of granulation-tissue formation in rats (Sikiric et al., 1999)

2025 Case report describes female sexual dysfunction temporally associated with GLP-1 agonists including semaglutide (hypothesis-generating mechanism)

Diabetes 60 , 21692178 (2011)

Wegovy has been shown to improve several metabolic markers: Reduced blood pressure Improved cholesterol profiles Enhanced insulin sensitivity Decreased inflammation markers These benefits may be particularly valuable for post-cholecystectomy patients with existing metabolic concerns